Cargando…
Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine
The development of age-appropriate formulations should focus on dosage forms that can deliver variable yet accurate doses that are safe and acceptable to the child, are matched to his/her development and ability, and avoid medication errors. However, in the past decade, the medication needs of neona...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600135/ https://www.ncbi.nlm.nih.gov/pubmed/31159216 http://dx.doi.org/10.3390/ijms20112688 |
_version_ | 1783431054576582656 |
---|---|
author | O’Brien, Fiona Clapham, David Krysiak, Kamelia Batchelor, Hannah Field, Peter Caivano, Grazia Pertile, Marisa Nunn, Anthony Tuleu, Catherine |
author_facet | O’Brien, Fiona Clapham, David Krysiak, Kamelia Batchelor, Hannah Field, Peter Caivano, Grazia Pertile, Marisa Nunn, Anthony Tuleu, Catherine |
author_sort | O’Brien, Fiona |
collection | PubMed |
description | The development of age-appropriate formulations should focus on dosage forms that can deliver variable yet accurate doses that are safe and acceptable to the child, are matched to his/her development and ability, and avoid medication errors. However, in the past decade, the medication needs of neonates have largely been neglected. The aim of this review is to expand on what differentiates the needs of preterm and term neonates from those of the older paediatric subsets, in terms of environment of care, ability to measure and administer the dose (from the perspective of the patient and carer, the routes of administration, the device and the product), neonatal biopharmaceutics and regulatory challenges. This review offers insight into those challenges posed by the formulation of medicinal products for neonatal patients in order to support the development of clinically relevant products. |
format | Online Article Text |
id | pubmed-6600135 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66001352019-07-16 Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine O’Brien, Fiona Clapham, David Krysiak, Kamelia Batchelor, Hannah Field, Peter Caivano, Grazia Pertile, Marisa Nunn, Anthony Tuleu, Catherine Int J Mol Sci Review The development of age-appropriate formulations should focus on dosage forms that can deliver variable yet accurate doses that are safe and acceptable to the child, are matched to his/her development and ability, and avoid medication errors. However, in the past decade, the medication needs of neonates have largely been neglected. The aim of this review is to expand on what differentiates the needs of preterm and term neonates from those of the older paediatric subsets, in terms of environment of care, ability to measure and administer the dose (from the perspective of the patient and carer, the routes of administration, the device and the product), neonatal biopharmaceutics and regulatory challenges. This review offers insight into those challenges posed by the formulation of medicinal products for neonatal patients in order to support the development of clinically relevant products. MDPI 2019-05-31 /pmc/articles/PMC6600135/ /pubmed/31159216 http://dx.doi.org/10.3390/ijms20112688 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review O’Brien, Fiona Clapham, David Krysiak, Kamelia Batchelor, Hannah Field, Peter Caivano, Grazia Pertile, Marisa Nunn, Anthony Tuleu, Catherine Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine |
title | Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine |
title_full | Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine |
title_fullStr | Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine |
title_full_unstemmed | Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine |
title_short | Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine |
title_sort | making medicines baby size: the challenges in bridging the formulation gap in neonatal medicine |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600135/ https://www.ncbi.nlm.nih.gov/pubmed/31159216 http://dx.doi.org/10.3390/ijms20112688 |
work_keys_str_mv | AT obrienfiona makingmedicinesbabysizethechallengesinbridgingtheformulationgapinneonatalmedicine AT claphamdavid makingmedicinesbabysizethechallengesinbridgingtheformulationgapinneonatalmedicine AT krysiakkamelia makingmedicinesbabysizethechallengesinbridgingtheformulationgapinneonatalmedicine AT batchelorhannah makingmedicinesbabysizethechallengesinbridgingtheformulationgapinneonatalmedicine AT fieldpeter makingmedicinesbabysizethechallengesinbridgingtheformulationgapinneonatalmedicine AT caivanograzia makingmedicinesbabysizethechallengesinbridgingtheformulationgapinneonatalmedicine AT pertilemarisa makingmedicinesbabysizethechallengesinbridgingtheformulationgapinneonatalmedicine AT nunnanthony makingmedicinesbabysizethechallengesinbridgingtheformulationgapinneonatalmedicine AT tuleucatherine makingmedicinesbabysizethechallengesinbridgingtheformulationgapinneonatalmedicine |